NCT03576183: A trial that was reported late by Valneva Austria GmbH
This trial has reported, although it was 369 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03576183 |
|---|---|
| Title | Randomized Double-Blinded Pilot Study Confirming A Human Challenge Model Using LSN03-016011/A Expressing LT And CS17 And Investigating The Safety Of VLA1701 (An Investigational Oral Cholera And ETEC (Enterotoxigenic E Coli) (Vaccine) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 4, 2018 |
| Completion date | June 26, 2018 |
| Required reporting date | June 26, 2019, midnight |
| Actual reporting date | June 29, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 369 |